Literature DB >> 16038620

Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology.

Douglas C Bittel1, Merlin G Butler.   

Abstract

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder that arises from lack of expression of paternally inherited genes known to be imprinted and located in the chromosome 15q11-q13 region. PWS is considered the most common syndromal cause of life-threatening obesity and is estimated at 1 in 10,000 to 20,000 individuals. A de novo paternally derived chromosome 15q11-q13 deletion is the cause of PWS in about 70% of cases, and maternal disomy 15 accounts for about 25% of cases. The remaining cases of PWS result either from genomic imprinting defects (microdeletions or epimutations) of the imprinting centre in the 15q11-q13 region or from chromosome 15 translocations. Here, we describe the clinical presentation of PWS, review the current understanding of causative cytogenetic and molecular genetic mechanisms, and discuss future directions for research.

Entities:  

Mesh:

Year:  2005        PMID: 16038620      PMCID: PMC6750281          DOI: 10.1017/S1462399405009531

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  109 in total

1.  Gait patterns in Prader-Willi and Down syndrome patients.

Authors:  Veronica Cimolin; Manuela Galli; Graziano Grugni; Luca Vismara; Giorgio Albertini; Chiara Rigoldi; Paolo Capodaglio
Journal:  J Neuroeng Rehabil       Date:  2010-06-21       Impact factor: 4.262

Review 2.  When ribosomes go bad: diseases of ribosome biogenesis.

Authors:  Emily F Freed; Franziska Bleichert; Laura M Dutca; Susan J Baserga
Journal:  Mol Biosyst       Date:  2010-01-11

3.  Management of obesity in Prader-Willi syndrome.

Authors:  Merlin G Butler
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2006-11

4.  Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome.

Authors:  Duane T Brandau; Mariana Theodoro; Uttam Garg; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2008-03-01       Impact factor: 2.802

Review 5.  Epigenetics, autism spectrum, and neurodevelopmental disorders.

Authors:  Sampathkumar Rangasamy; Santosh R D'Mello; Vinodh Narayanan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

6.  EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.

Authors:  M G Butler; T A Nelson; D J Driscoll; A M Manzardo
Journal:  J Rare Disord       Date:  2015-09

7.  An interstitial 15q11-q14 deletion: expanded Prader-Willi syndrome phenotype.

Authors:  Merlin G Butler; Douglas C Bittel; Nataliya Kibiryeva; Linda D Cooley; Shihui Yu
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

8.  Sleep disordered breathing in infants with Prader-Willi syndrome during the first 6 weeks of growth hormone therapy: a pilot study.

Authors:  Jennifer L Miller; Jonathan Shuster; Douglas Theriaque; Daniel J Driscoll; Mary Wagner
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

9.  Herlyn-Werner-Wunderlich and Prader-Willi syndromes: more than a coincidence?

Authors:  Beatriz Fraga; Catarina Gomes; Raquel Gouveia; Graça Oliveira
Journal:  BMJ Case Rep       Date:  2015-10-21

10.  Development and implementation of electronic growth charts for infants with Prader-Willi syndrome.

Authors:  S Trent Rosenbloom; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.